SFARI consultant-in-residence Gaspar Taroncher-Oldenburg discusses his work and collaboration with the Simons Foundation Flatiron Institute to study the microbiome and its potential implications for ASD research.
SFARI Investigator Kevin Eggan discusses his research on induced pluripotent stem (iPS) cells and his collaboration with SFARI to provide a detailed characterization of iPS cell lines from Simons Searchlight participants.
On July 29, 2020, SFARI convened an online workshop to explore environmental (maternal and fetal) risk factors for autism spectrum disorder in the context of COVID-19 infection.
In October and November 2021, SFARI held the fall 2021 science meeting virtually. Across three webinars, nine SFARI-funded researchers discussed their latest findings in autism research to an audience of over 300 attendees, including current and past SFARI Investigators, SFARI collaborators and postdocs training in SFARI-funded labs.
SFARI is pleased to announce that eight Director Awards were awarded in 2020. These projects include, but are not limited to, studies that aim to enhance existing SFARI-sponsored cohorts and collections, generate novel resources (e.g., animal models) and studies whose goals are beyond the focus of existing SFARI request for applications.
SFARI reminds all approved Principal Investigators that the use of data sets and/or biospecimens obtained from the SFARI Simons Collection is subject to certain limitations and that these resources cannot be shared or distributed to any other researchers without prior SFARI approval.
Researchers interested in requesting brain tissue from Autism BrainNet can now submit their applications through SFARI Base, SFARI’s clearinghouse for autism and autism-related research data and biospecimens.
SFARI is pleased to announce that it intends to fund seven grants in response to the Autism Rat Models Consortium request for applications.
The Simons Variation in Individuals Project (Simons VIP) is studying individuals with recurrent genetic variants that increase autism risk.
This issue of the SFARI newsletter includes: (1) SFARI Summer 2020 Pilot awardees, (2) SPARK update: New phenotypic data now available, (3) Simons Searchlight: Research matching program launched, (4) SFARI Gene: January 2021 data release, (5) SfN Global Connectome: Presentations by SFARI Investigators, (6) SFARI Bridge to Independence fellows discuss new research findings and career challenges at virtual retreat, (7) SFARI blog: Alice Luo Clayton, “SFARI Bridge to Independence Award program: Looking back, looking forward”, (8) Highlights of SFARI-funded research, (9) 2021 Bridge to Independence Award— Request for applications, (10) Maternal COVID-19 as a Potential Risk for Autism: Supplemental Funding for Ongoing Pregnancy cohorts – Request for applications, (11) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications, (12) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (13) Upcoming lecture: Elizabeth Berry-Kravis, “Clinical trials and cyclic AMP in fragile X syndrome: A life journey.”